Skip to main content
SpringerLink
Log in

Regulatory T cells in Behçet’s disease: Is there a correlation with disease activity? Does regulatory T cell type matter?

  • Original Article
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

The aim of this study was to investigate the percentage of regulatory T cells and the correlation with clinical activity in Behçet’s disease. Forty Behçet’s disease (BD) patients, 18 males and 22 females, were included in the study. The patients were diagnosed according to the published BD criteria. Twenty age- and sex-matched volunteer healthy donors were also included. At the time of sampling, clinical activity was assessed for activity signs and symptoms according to the BD Current Activity Form. We considered active those patients with a clinical activity index equal to and/or above 2. Eleven patients had active disease and the remaining were considered as clinically inactive. We have studied the percentages of CD4+CD25+FOXP3+, CD4+CD25+ and CD4+FOXP3+regulatory T cells by flow cytometry and investigated the correlation with disease activity. Percentage of CD4+CD25+FOXP3+Treg in active patients was lower than clinically inactive patients and healthy controls. Percentage of CD4+CD25+Treg was not different between active and inactive patients and healthy controls. Percentage of CD4+FOXP3+Treg was lower than healthy controls in clinically active patients but was not different for inactive group and healthy controls. Patients were active when CD4+CD25+FOXP3+Treg was ≤1.19 %, CD4+CD25+Treg was ≤2.68 %, and CD4+FOXP3+Treg was ≤2.60. CD4+CD25+FOXP3+Treg and CD4+FOXP3+Treg were found negatively correlated with disease activity. Peripheral blood regulatory T cells are decreased in clinically active Behçet’s disease patients. The advances in our understanding of the interactions between distinct subsets of Treg and clinical activity might help in modulating BD treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Sakane T, Takeno M, Suzuki N, Inaba G (1999) Behçet’s disease. N Engl J Med 341:1284–1291

    Article  PubMed  CAS  Google Scholar 

  2. McGonagle D, McDermott MF (2006) A proposed classification of the immunological diseases. PLos Med 3:1242–1248

    Article  CAS  Google Scholar 

  3. Andersson J, Tran DQ, Pesu M, Davidson TS, Ramsey H, O’Shea JJ et al (2008) CD4+FoxP3+regulatory T cells confer infectious tolerance in a TGF-beta-dependent manner. J Exp Med 205:1975–1981

    Article  PubMed  CAS  Google Scholar 

  4. McMurchy AN, Bushell A, Levings MK, Wood KJ (2011) Moving to tolerance: clinical application of T regulatory cells. Sem Immunol 23:304–313

    Article  CAS  Google Scholar 

  5. International Study Group for Behçet’s Disease (1990) Criteria for diagnosis of Behçet’s disease. Lancet 335:1078–1080

    Google Scholar 

  6. Bhakta BB, Brennan P, James TE, Chamberlain MA, Noble BA, Silman AJ (1999) Behçet’s disease: evaluation of a new instrument to measure clinical activity. Rheumatology 38:728–733

    Article  PubMed  CAS  Google Scholar 

  7. deChambrun MP, Wechsler B, Geri G, Cacoub P, Saadoun D (2012) New insights into the pathogenesis of Behçet’s disease. Autoimmune Rev 11:687–698

    Article  Google Scholar 

  8. Fontenot JD, Gavin MA, Rudensky AY (2003) Foxp3 programs the development and function of CD4+CD25+regulatory T cells. Nat Immunol 4:304–306

    Article  Google Scholar 

  9. Allan SE, Crome SQ, Crellin NK, Passerini L, Steiner TS, Bacchetta R et al (2007) Activation induced Foxp3 in human T effector cells does not suppress proliferation or cytokine production. Int Immunol 19:345–354

    Article  PubMed  CAS  Google Scholar 

  10. Nanke Y, Kotake S, Goto M, Ujihara H, Matsubara M, Kamatni N (2008) Decreased percentages of regulatory T cells in peripheral blood of patients with Behçet’s disease before ocular attack: a possible predictive marker of ocular attack. Mod Rheumatol 18:354–358

    Article  PubMed  Google Scholar 

  11. Hamzaoui K, Borhani Haghighi A, Ghorbel IB, Houman H (2011) RORC and Foxp3 axis in cerebrospinal fluid of patients with neuro-Behçet’s disease. J Neuroimmunol 50:249–253

    Article  Google Scholar 

  12. Pekiner FN, Aytugar E, Demirel GY, Borahan MO (2012) Interleukin-2, interleukin-6 and T regulatory cells in peripheral blood of patients with Behçet’s disease and recurrent aphthous ulcerations. J Oral Pathol Med 14:73–79

    Article  Google Scholar 

  13. Hamzaoui K (2007) Paradoxical high regulatory T cell activity in Behçet’s disease. Clin Exp Rheumatol 25:107–113

    Google Scholar 

  14. Hamzaoui K, Hamzaoui A, Houman H (2006) CD4+CD25+regulatory T cells in patients with Behçet’s disease. Clin Exp Rheumatol 24:71–78

    Google Scholar 

  15. Geri G, Terrier B, Rosenzwajg M, Wechsler B, Touzot M, Seilhean D et al (2011) Critical role of IL-21 in modulating T(H)17 and regulatory T cells in Behçet’s disease. J Allergy Clin Immunol 128:655–664

    Article  PubMed  CAS  Google Scholar 

  16. Liang L, Wang H, Peng XY, Zhao M (2011) The changes of Th lymphocyte subsets in patients with Behcet disease. Zhonghua Yan Ke Za Zhi 47:393–397

    PubMed  Google Scholar 

  17. Mochizuki M, Morita E, Yamamoto S, Yamana S (1997) Characteristics of T cell lines established from skin lesions of Behçet’s disease. J Dermatol Sci 15:9–13

    Article  PubMed  CAS  Google Scholar 

  18. Sugita S, Yamada Y, kaneko S, Horie S, Mochizuki M (2011) Induction of regulatory T cells by infliximab in Behçet’s disease. IOVS 52:476–484

    CAS  Google Scholar 

  19. Bluestone JA (2005) Regulatory T cell therapy: is it ready for the clinic? Nat Rev Immunol 5:343–349

    Article  PubMed  CAS  Google Scholar 

  20. Tang Q, Henriksen KJ, Bi M, Finger EB, Szot G, Ye J et al (2004) In vitro expanded antigen specific regulatory T cells suppress autoimmune diabetes. J Exp Med 199:1455–1465

    Article  PubMed  CAS  Google Scholar 

  21. Furtado GC, Olivares-Villagomez D, Curotto de Lafaille MA, Wensky AK, Latkowski JA, Lafaille JJ (2001) Regulatory T cells in spontaneous autoimmune encephalomyelitis. Immunol Rev 182:122–134

    Article  PubMed  CAS  Google Scholar 

  22. Shim J, Lee ES, Park S, Bang D, Sohn S (2011) CD4+CD25+regulatory T cells ameliorate Behçet’s disease like symptoms in a Mouse model. Cytotherapy 13:835–847

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Hematology, School of Medicine, Eskişehir Osmangazi University, Eskisehir, 26480, Turkey

    Eren Gündüz & Hava Üsküdar Teke

  2. Department of Rheumatology, School of Medicine, Eskişehir Osmangazi University, Eskisehir, Turkey

    Nazife Şule Yaşar Bilge, Döndü Üsküdar Cansu & Cengiz Korkmaz

  3. Department of Biostatistics, School of Medicine, Eskişehir Osmangazi University, Eskisehir, Turkey

    Cengiz Bal

  4. Bone Marrow Transplantation Center, Anadolu Health Center, Gebze, Turkey

    Zafer Gülbaş

Authors
  1. Eren Gündüz
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hava Üsküdar Teke
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Nazife Şule Yaşar Bilge
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Döndü Üsküdar Cansu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Cengiz Bal
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Cengiz Korkmaz
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Zafer Gülbaş
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Eren Gündüz.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gündüz, E., Teke, H.Ü., Bilge, N.Ş.Y. et al. Regulatory T cells in Behçet’s disease: Is there a correlation with disease activity? Does regulatory T cell type matter?. Rheumatol Int 33, 3049–3054 (2013). https://doi.org/10.1007/s00296-013-2835-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-013-2835-8

Keywords

Search

Navigation